SCHEMBL18923652

SCHEMBL18923652

CC(C)c1cccc(P)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
ALOX12 P18054 2/20 0.47
HTT P42858 2/20 0.47
MDM4 O15151 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
TYR P14679 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
CA5A P35218 1/20 0.47
MDM2 Q00987 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA9 Q16790 1/20 0.47
HDAC2 Q92769 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27895270 0.98 HDAC4 (0.45) HDAC4HDAC8KDM4EALDH1A1ALOX12
Hydrochloric Acid SCHEMBL4454669 0.95 HDAC4 (0.44) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL20591157 0.88 KDM4E (0.39) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL374780 0.81 HDAC4 (0.56) HDAC4HDAC8KDM4EALDH1A1ALOX12
Benzene SCHEMBL7084450 0.78 HDAC4 (0.54) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL11036540 0.78 HDAC4 (0.54) HDAC4HDAC8KDM4EALDH1A1ALOX12
Hydrochloric Acid SCHEMBL28429663 0.78 HDAC4 (0.54) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL31122172 0.78 HDAC4 (0.54) HDAC4HDAC8KDM4EALDH1A1ALOX12
Water SCHEMBL9322811 0.78 HDAC4 (0.54) HDAC4HDAC8KDM4EALDH1A1ALOX12
SCHEMBL19031518 0.78 KDM4E (0.54) HDAC4HDAC8KDM4EALDH1A1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365525-A1 ANTIVIRAL COMPOUNDS ENANTA PHARMACEUTICALS, INC. 2023-11-16 US disclosed
US-20230371357-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-11-16 US disclosed
US-20220280488-A1 PHARMACEUTICALLY ACTIVE PYRAZOLO-PYRIDONE MODULATORS OF DCN1/2-MEDIATED CULLIN NEDDYLATION UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2022-09-08 US disclosed
CN-110003271-B Process for producing aromatic compound 住友化学株式会社 2022-05-03 CN disclosed
US-20210047287-A1 NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2021-02-18 US disclosed
US-20200397774-A1 PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS INCYTE HOLDINGS CORPORATION 2020-12-24 US disclosed
CN-110003271-A The preparation method of aromatic compound 住友化学株式会社 2019-07-12 CN disclosed
US-20190055204-A1 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. 2019-02-21 US disclosed
US-9670201-B2 Methyl- and trifluoromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof PFIZER INC. (US) 2017-06-06 US disclosed
CN-106083927-A Phosphinyl amidine compound, metal complex, antigravity system and their oligomeric or purposes of olefin polymerization 切弗朗菲利浦化学公司 2016-11-09 CN disclosed
CN-1898304-A Method for bonding polybutadiene molded article, polybutadiene composite molded article obtained by the method, medical member, and infusion device JSR CORP (JP) 2007-01-17 CN disclosed
CN-1223616-C 1, 2-polybutadiene, thermoplastic elastomer composition and polymer composition JSR CORP (JP) 2005-10-19 CN disclosed
CN-1215068-C Prepn process of 2,3,3',4'-diphenyl tetraformic dianhydride and its derivative CHANGCHUN APPLIED CHEMISTRY (CN) 2005-08-17 CN disclosed
CN-1583188-A Medical member and medical instrument JSR CORP (JP) 2005-02-23 CN disclosed
CN-1189597-C Preparation of biphenylyl tetra formicdianhydride and its derivative using electrochemical method CHANGCHUN APPLIED CHEMISTRY (CN) 2005-02-16 CN disclosed
CN-1511176-A Oil extended 1,2-polybutadiene and method of manufacturing polybutadiene, and composition and formed product thereof JSR株式会社 2004-07-07 CN disclosed
CN-1454221-A 1, 2-polybutadiene, thermoplastic elastomer composition and polymer composition JSR CORP (JP) 2003-11-05 CN disclosed
CN-1436780-A Prepn process of 2,3,3',4'-diphenyl tetraformic dianhydride and its derivative CHANGCHUN APPLIED CHEMISTRY (CN) 2003-08-20 CN disclosed
CN-1410598-A Preparation of biphenylyl tetra formicdianhydride and its derivative using electrochemical method CHANGCHUN APPLIED CHEMISTRY (CN) 2003-04-16 CN disclosed
CN-1278834-A gas phase polymerization of vinyl polybutadiene UNION CARBIDE CHEM PLASTIC (US) 2001-01-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220280488-A1 PHARMACEUTICALLY ACTIVE PYRAZOLO-PYRIDONE MODULATORS OF DCN1/2-MEDIATED CULLIN NEDDYLATION CUL1, CUL2, NEDD8 HDAC4 667/4885HDAC8 739/4885KDM4E 2253/4885
US-20200397774-A1 PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS JAK1, JAK2, JAK3 HDAC4 1067/4885HDAC8 1653/4885KDM4E 248/4885
US-20230371357-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE L1CAM, CHRM1, FOXM1 HDAC4 4574/4885HDAC8 4643/4885KDM4E 3285/4885
US-20210047287-A1 NONPEPTIDE SOMATOSTATIN TYPE 5 RECEPTOR AGONISTS AND USES THEREOF SSTR5, SSTR4, SSTR3 HDAC4 1310/4885HDAC8 1275/4885KDM4E 4514/4885
US-20230365525-A1 ANTIVIRAL COMPOUNDS ACE, ZC3HAV1, SARS1 HDAC4 1252/4885HDAC8 2434/4885KDM4E 1688/4885
US-20190055204-A1 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF GRM5, GRM2, GRM1 HDAC4 747/4885HDAC8 682/4885KDM4E 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.